Association of Antenatal Steroid Exposure at 21 to 22 Weeks of Gestation With Neonatal Survival and Survival Without Morbidities

IMPORTANCE: The provision of antenatal corticosteroids to pregnant patients at gestational age (GA) 22 6/7 weeks or less remains controversial and lacks support from randomized clinical trials. OBJECTIVE: To compare rates of survival and survival without major morbidities among infants born at GA 22...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawla, Sanjay, Wyckoff, Myra H., Rysavy, Matthew A., Patel, Ravi Mangal, Chowdhury, Dhuly, Natarajan, Girija, Laptook, Abbot R., Lakshminrusimha, Satyan, Bell, Edward F., Shankaran, Seetha, Van Meurs, Krisa P., Ambalavanan, Namasivayam, Greenberg, Rachel G., Younge, Noelle, Werner, Erika F., Das, Abhik, Carlo, Waldemar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513645/
https://www.ncbi.nlm.nih.gov/pubmed/36156145
http://dx.doi.org/10.1001/jamanetworkopen.2022.33331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513645/
https://www.ncbi.nlm.nih.gov/pubmed/36156145
http://dx.doi.org/10.1001/jamanetworkopen.2022.33331

Ejemplares similares